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REVIEW OF LITERATURE
SOYBEAN PRODUCTS AS A PROTEIN SOURCE IN MILK REPLACER
FOR PRERUMINANT CALVES.
The development of milk substitutes
The first successful substitutes for whoie milk were developed around
1950. Previously, milk replacers had really been milk extenders and
consisted of linseed oil meal, wheat middlings, wheat red dog and oat flour.
These were fed as gruels and were only successful if given together with
whole milk (18,64). The early commercial milk replacers were, in fact,
largely composed of milk derivatives. Thus, dried skim milk was the
principle source of protein and carbohydrate, while tallow provided the lipid
fraction. The major problem with these early milk replacers was poor
growth rates due to the low energy content; only limited amounts (<10 %)
of fat could be added without clogging the batch m beers. Advances in
processing technology solved the problem of restricted fat addition by
homogenization of the mixture followed by spray drying (59). Another
problem with the early milk replacers included excessive scouring following
overheating of the skim milk during drying. This problem was solved by
preheating to 60-74°C for 30 min before spray drying (59).
In 1966, due to a change in price support policy, the relative cost of
skim milk increased. As a result of these changes, manufacturers turned to
casein and whey as alternative protein and carbohydrate sources,
respectively. These products proved to be of comparable quality to the skim
milk-based products. In 1971 the U.S. government changed policies from
subsidized milk production to subsidized slaughter of dairy cows and milk
disposal programs. In the same period Australia and New Zealand, both
important producers of casein for the world market, suffered drought and
reduced casein production. The subsequent increase in casein prices
stimulated renewed interest in non-dairy sources of protein and caused milk
replacer manufacturers to use whey as the major source of protein.
Carbohydrate replacement in milk replacers
The young preruminant calf can successfully digest only lactose
among the oligosaccharides, because lactase (B-galactasidase) is the only
brush border enzyme secreted in significant amounts (36,64). Invertase is
absent, consequently calves are unable to utilize sucrose (71). Seme maltase
has been found (10), but the absence of salivary amylase (10,36,51) and the
relatively low secretion of pancreatic amylase (36,51,71) limits the capacity
of the preruminant calf to digest starch. According to Thivend (94), calves
under 8 wks of age cannot utilize more than 15% of the dry matter in their
diets as starch and this has to be reached by gradual increase. Milk
replacers generally contain lactose, in the form of whey, as their
carbohydrate source. Glucose, though available to the calf, is comparatively
expensive. Carbohydrate cannot be used as the major energy source,
because hexose absorptive capacity is limited (17). Should excessive
carbohydrate, or carbohydrate of a type unavailable to the calf be given,
calves become predisposed to fermentative diarrhea (69). Such is the case
(exacerbated by high mineral content) when using large amounts of dried
whey, which has not been ultrafiltered, or when a large amount of soy flour
is used.
Lipid replacement in milk replacers
Carbohydrate absorption is limited, therefore lipids are needed if a
milk replacer is to supply sufficient energy for rapid growth. The digestion
of fat in the preruminant calf is accomplished by pregastric esterase and
pancreatic lipase (55). Much of the early work on the use of alternative
lipids gave poor results because of a deficiency of the fat soluble vitamin
E- With supplementation of vitamins the list of viable alternative lipid
sources is somewhat increased (68). There are several sources of lipids used
in milk replacers, with choice white grease and tallow being the most
common (74). Other lipids used in milk replacers include partially
hydrogenated fish oil, palm oil and sunflower oil (59,74). Milk replacer trials
in which cotton seed oil or soybean oil was the energy source resulted in
unthriftiness, excessive scouring and high mortality, this poor response
being partially alleviated by hydrogenation of the unsaturated oils (4,52).
Homogenization and emulsification of lipids in milk replacers is thought to
improve their utilization (71). Soy lecithin is normally added to improve
lipid emulsification. After homogenization and emulsification the
digestibility of choice white grease and tallow approaches that of butterfat
(73). Another benefit of fat addition is a reduction in scours, with the
effect being somewhat proportional to the amount of fat (11,59).
Protein replacement in milk replacers
Protein requirements of the preruminant calf. The requirements of
the preruminant calf for digestible protein are dependent upon body weight,
rate of gain and age (19,69). The recommended concentration of protein in
milk replacers is 22 % (54). This recommendation is for milk replacers
containing high quality milk protein. Roy et al. (71) proposed utilization of
milk replacers with higher protein levels if protein sources of lower
biological value than milk protein were used. This theory is supported in
work by Akinyele and Harsbarger (1). However, other studies have shown no
benefit to feeding milk replacers with higher protein levels to compensate
for poor biological value of ingredients (14,56).
In estimating amino acid requirements, the relationship between the
carcass content of a reference amino acid and the average dietary
requirement for the same amino acid is found. This relationship is used to
estimate the requirements of other amino acids relative to their carcass
composition. The method assumes the relationship between carcass
composition and dietary requirement is proportional, that rates of turnover
of all amino acids in the body are similar and absorption of all amino acids
is the same. Differences in estimating amino acid requirements were
observed when lysine was used as the reference amino acid rather than
methionine (102). Methionine is required in methyl transfer reactions and
this fraction of the absorbed methionine does not become part of the
carcass tissue; also cystine can have a sparing effect on methionine.
Radostits and Bell (64) reported that apparent digestibility of methionine
was lower than that of the other essential amino acids. Such factors help
explain the range in values given for amino acid requirements. Some of the
essential amino acid requirements of the calf have been determined
(21,60,102).
Non-milk protein in milk replacer. Huber (35) compared the relative costs of
using skim milk powder, fish products and soy flour as protein sources in
milk replacers. The economic benefits of these alternative proteins were
quite substantial. However, performance of calves has been inadequate when
these products supply more than 30-40 % of the dietary protein. Thus, there
is an interest in developing or discovering a non-milk protein which is
economical, while allowing high calf growth rates. A number of materials
have been tested as a non-dairy protein source for milk replacers (59,66,90).
Most non-dairy proteins have undesirable effects on calf performance when
used as the major protein. Use of some products is discouraged by limited or
unreliable supply; many of the animal by-products come into this category.
Some of the alternative proteins tested appear to have nutritional potential
but require further study and currently lack the production infrastructure
needed. Pea (9) and alfalfa protein concentrates (2) come into this
category.
The two most extensively studied non-milk protein sources for use in
milk replacers are fish and soybeans. These two base products have
widespread international production and utilization, with reliable supply.
Both fish and soybeans have proved unsuitable as the major protein in milk
replacer in their more common forms, and as a result have undergone
extensive study in an attempt to provide a protein devoid of deleterious
side effects.
Fish as a protein in milk replacers for calves
Replacement of a major portion of milk replacer protein with fish
protein concentrate can result in reduced diet palatability, poor calf
growth, and a reduction in the quality, both taste and appearance, of veal
(13,27,35,40,58). Huber (35) reviewed some of the effects of using fish
products as a protein source. The organic solvent used to extract fish
protein affects the quality of the final product. Dichloroethane (DCE)
extraction results in a superior product for milk replacers, compared to
isopropanol (ISO) extraction, or hexane-heptane (HH) extraction. At least
part of the difference between end products is due to the toxicity of
residues. Fish protein solubles have an unfavorable amino acid balance. Fish
products are deficient in vitamin E; while the iron content is sufficient to
reduce the anemia necessary for light colored veal (98). Though inferior to
milk, "satisfactory" calf performance has been obtained with the use of ISO
extracted herring meal, together with NaOH neutralized acid whey (27).
In summary, ISO extracted fish protein concentrate, with
supplemental vitamin E, can be used to supply up to 35% of the protein in a
milk replacer for young «3 wk old) non-veal calves. As calves age beyond 3
wks, particularly when given dry feed, fish protein concentrate can
successfully provide around 70 % of the protein in a milk replacer (35).
Soybeans in milk replacers for calves
Soybeans can be divided into three fractions of major interest to a
manufacturer of milk replacer; lipid, carbohydrate and protein.
The earliest attempts at using soy products in a milk replacer
involved full-fat soybean meal. These early soy-based products resulted in
diarrhea, loss of appetite, muscular weakness, poor growth and high
mortality (78,103). In studies where soy oil was used as the lipid source in a
skim milk based milk replacer, unthriftiness, excessive scouring and high
mortality resulted (4,52). In consequence of this and the relatively high
value of soy oil, subsequent studies have largely concentrated on lipid
extracted soy products.
Carbohydrate composes approximately 1/3 of a soy flour, with roughly
half of this being soluble (34). The soluble sugars are unavailable to the
calf, but can undergo microbial fermentation with resultant flatulence and
diarrhea (69). The insoluble carbohydrate fraction consists largely of
pectins, arabinogalactans and cellulose; these are not readily fermentable
and therefore not thought to be detrimental to the calf. Enzymatic
pre-digestion of the carbohydrates in soy flour failed to improve its
utilization by calves (16). Further, the feeding of soy protein concentrates
and soy protein isolates (which have their soluble carbohydrates removed
during processing) generally fails to produce satisfactory calf performance
(56,57). It therefore seems that the carbohydrate component of soybeans has
at least the potential for a detrimental effect on calf performance, and
that major problems remain with the proteins themselves.
Problems associated with soy proteins in milk replacers for calves
There are numerous anti-nutritional factors associated with soy
proteins. Some of these have been studied extensively, while others have
received little attention. The less well known effects include: inhibition of
iodine uptake by the thyroid, resulting in goiter; having antithyrotoxic,
estrogenic and rachitogenic properties (105); and reducing uptake of dietary
copper and zinc (33). Other effects of soybeans have received greater
attention.
Hemagglutinin. Raw soybeans contain the toxin hemagglutinin.
Hemagglutinin is readily inactivated by heat, acid, alkali or pepsin. It is
therefore, not considered to be of importance in processed soy products (5).
Urease. Present in raw soybeans, urease is inactivated by heat, with
moisture an important cofactor, in a manner similar to trypsin inhibitor
(106). Urease has no physiological activity in the monogastric animal and is
therefore of little importance in milk replacers. The importance of urease
lies in the correlation between its activity and those of trypsin inhibitor
and lipase inhibitor. This, together with the simple assay procedure for
urease, led to its use as a means of determining the efficacy of heat
processing (5,83,106,). However, the use of urease in quality control is
limited, it having been shown that urease activity does not always reflect
trypsin inhibitor activity (22).
Lipase inhibitor. Soybean lipase inhibitor acts by binding to the
substrate, rather than the enzyme (73). Purified lipase inhibitor is
inactivated at temperatures above 50°C unless the substrate is emulsified,
whereupon it remains active at 60°C (73). Little is known about the
occurrence and activity of lipase inhibitor in oil-extracted soy products.
Trypsin inhibitor. The problem with trypsin inhibitor (TI), or more
correctly trypsin inhibitors, is more complex than with the other inhibitors.
Reviews by Flavin (20) and Wright (106) indicate there are at least 5
different TIs in soybeans. Differences between these TIs include their
ability to inhibit trypsin and their susceptibility to inactivation by
processing. To further complicate matters, the assay used to measure TI
only registers the activity of TI in solution. It has been shown that
inactive-bound TI can become active following a change in conditions, such
as pH (67).
The mode of action of TI has been established in the rat (20). In this
case the TI binds with trypsin, forming an inactive enzyme-inhibitor
complex. This in turn decreases both proteolytic activity and negative
feedback on trypsin secretion via colecystekinin. The results are a decrease
in protein digestion and pancreatic hypertrophy due to sustained stimulation
of pancreatic secretion. The effects of TI in the calf differs from those of
the rat, as indicated by a lack of pancreatic hypertrophy (28,30). Further,
there is some evidence to suggest reduced pancreatic secretion following
the feeding of soy proteins to calves (28,30,104). These facts indicate
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pancreatic activity in the rat and calf have different regulatory
mechanisms. This is not to say that soy TI does not inhibit the proteolytic
activity of bovine trypsin. In vitro inhibition of bovine trypsin by soy TI is
100% at a 1:1 molar ratio, compared to 35% inhibition of human trypsin
under similar conditions (20).
Several authors have correlated calf performance to the TI activity
of milk replacer; some studies find a significant inverse relationship
(28,101), while others fail to show any significant relationship, even when
adding exogenous TI (43,66). The controversy may in part be due to
limitations of the TI assay by its reliance upon the soluble-active portion of
the total TI. Alternatively, calf performance may be related to some other
component of the soy product, which sometimes reflects TI activity but is
essentially independent of it. There is no clear evidence that the
inactivation of TI
.
during processing accounts for the improved protein
digestion and calf performance generally seen with heated soy flours.
Evidence from rats suggests that removal of TI without heating results in
40% of the improvement seen with heating (42). It seems likely there would
be some benefit, to the preruminant calf, from the inactivation of TL
TI activity is reduced by heating, and some form of heat treatment is
standard for soy products used in milk replacers. TI activity is inversely
related to time and temperature of heating, with moisture an important
cofactor. Most researchers find a marked improvement in calf performance
with heated soy products over non-heated soy products (5,15,43,56,101).
However, excessive heating causes poor product quality by reducing both
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palatabUity and amino acid availability through the Maillard reaction
(15,19).
Antigenicity of the soy proteins. Soy protein products, which have
undergone processing to remove or inactivate the anti-nutritional factors
mentioned above, do not generally produce milk replacers of the predicted
high quality. One possible reason for this is an allergic sensitivity of the
preruminant calf to soy proteins. Such a reaction was first indicated in
1965, with the discovery of antibody formation in response to diets
containing soy flours (97). That an immune hypersensitivity can occur has
been confirmed and further studied by several authors (6,7,8,44,85,88). The
antigenic proteins have been isolated and identified as glycinin and
fi-conglycinin, two of the major storage proteins of soybeans. Further
evidence for the involvement of soy protein antigens in the malnutrition of
soy-fed calves comes from studies of the small intestine. The effects of
diets, based on soy protein, on the rates of flow and composition of digesta
were studied in the abomasum and small intestine of fistulated preruminant
calves (84). Feeding soy proteins resulted in an inhibition of abomasal
emptying, decreased transit time through the small intestine, abnormal salt
and water exchange and decreased nitrogen absorption. When first
introduced, the soy diets gave comparatively "normal" digesta movements;
abnormalities were only exhibited in animals previously fed soy protein and
generally coincided with demonstrable serum antibodies against soy proteins.
Associated with the development of the immune response and the digestive
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disturbances are changes in the intestinal mucosa. These include villous
atrophy, crypt hyperplasia, mononuclear cellular infiltration of the lamina
propria and villi, and edema and hemorrhage within the laminal tissue
(8,61,76,77,79,80). There is also a breakdown in the integrity of the mucosal
barrier, allowing passage of macromolecules into the circulatory systems
(45). Changes in the intestinal mucosa, particularly the decrease in surface
area associated with villous atrophy, together with the decreased transit
time of digesta across the small intestine, are thought to be responsible for
a decrease in the absorptive ability of the small intestine (13,76,77,79).
Barrat and Porter (6,7,8) studied the immunoglobulins involved in the
immune response of calves to soy proteins. Antigen precipitating,
complement fixing, IgG (immunoglobulin G) antibody is the major anti-soy
immunoglobulin in the serum of soy fed calves. A small percentage of calves
develop detectable serum IgE antibody. Immunoglobulin secretions into the
intestinal lumen differ in immunoglobulin class and specific activity. IgM
and IgA are the predominant immunoglobulins secreted into soy-perfused
intestinal loops of soy-sensitive calves, with IgG and IgE sometimes present.
Complement, activated by IgG-soy antigen complexes, causes the tissue
damage of the small intestine associated with feeding soy based milk
replacer. There is evidence suggesting the immune response by calves to the
soy protein is related to maternal (colostral) levels of anti-soy
immunoglobulins.
Studies in mice with transient dietary hypersensitivity have
implicated a cell-mediated immune reaction (91). A comparable etiology has
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been proposed to explain dietary hypersensitivity and post -weaning diarrhea
in the pig (48). No such response has been reported in calves given soy milk
replacer.
Amino acids of soy protein. Soy protein is considered relatively rich
in essential amino acids for a plant protein, only methionine and possibly
lysine being deficient. The extent of an amino acid deficiency in a milk
replacer is dependent upon the proportion of the protein supplied by soy
products and the source of the remaining protein. Williams and Hewitt (102)
suggest that up to 50% of a high quality milk protein can be replaced by
soy protein without an amino acid deficiency resulting. This is contradictory
to calculations by Jenkins and Emmons (39), who determined lysine to be
14% and methionine 2k% deficient with 55% replacement of milk protein by
soy protein. Similar controversy exists as to the effects of supplemental
amino acids; results range from a detrimental response (5), through no
response (26,89), to a beneficial response (39). These discrepancies could be
due to the range of values given for amino acid requirements, the variable
response of calves to apparently similar soy products and differences in the
availability of essential amino acids (28,49).
Evidence from rats, pigs, chicks and humans all indicate a methionine
deficiency in soy protein (5,48). A comparable deficiency of methionine for
the preruminant calf seems probable.
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Soybean products
Full-fat soy flour. Whole soybeans are dehulled and ground to produce
the basic full-fat soy flour. Products range from those given no additional
heat up to a toasted or fully cooked product. Toasted products are heated
to improve nutritional value. With the type of heat processing currently
given soy products this is the case when the destruction of antinutritional
factors is balanced by the loss of available essential amino acids (83). The
three important variables in standard heat processing are heat, moisture and
duration; they interact to determine the effectiveness of the heat
treatment (63). One result of this complexity in the heat treatment is that
each mill has individual processing conditions. Unfortunately, there is
variability in the final product, both between producers and between
batches from the same producer. There are several tests used to indicate
the effectiveness of heat treatment including the levels of urease, TI and
available lysine; the nitrogen solubility index (NSI); protein dispersable index
(PDI); and protein efficiency ratio (PER). The advantages, disadvantages and
use of these tests are reviewed by Horan (34). Full-fat soy flours are not
generally used in milk replacers due to the detrimental effects of the
carbohydrates and polyunsaturated oil.
Soy flour. More correctly called defatted soy flour, soy flours are
similar to full-fat soy flours, except for the absence of the lipid fraction.
The efficiency of lipid removal is dependant upon the extraction procedure.
The majority of manufacturers use the more efficient solvent extraction,
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reducing lipids to around 1% in the flour (34,83). Mechanical extraction
leaves around 5% lipids in the flour and is produced mainly as a speciality
item (34,83). Similar to the full-fat products, additional heat treatment
ranges from none up to toasting to optimum nutritional value. The same
tests of the efficacy of heat treatment can be used for full-fat and oil
extracted products. For use in a milk replacer a soy flour should be "fully
cooked". Soy flours receiving less than optimal heat treatment generally
produce correspondingly inferior results. However, even a fully cooked soy
flour results in poor calf performance if used to replace more than about
30% of the milk protein (16,57,71,78,90). The digestibility of soy flour
protein in milk replacer by 4-6 wk old calves has been estimated at 50%
(57).
Soy protein concentrate. Protein concentrates are made by heating
defatted soy flakes and then leaching out soluble materials with either
alcohol or acidic water (34). Most of the protein is retained in a protein
concentrate, while soluble oligosaccharides (sucrose, stacyose, raffinose) are
removed, as is much of the beany flavor associated with soy flours.
Insoluble sugars are not removed in concentrate processing, they remain
forming ca 20% of the product. Despite the increased cost of protein
concentrates, they are currently the most common soy protein products
found in milk replacers. The widespread use of soy protein concentrates in
milk replacers reflects increased calf performance over heated soy flours
(28,57). Though a soy concentrate allows a superior milk replacer to soy
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flour, it remains inadequate for high level protein replacement (13,28,50,57).
The digestibility of protein from a soy protein concentrate in milk replacer
fed 4-6 wk old calves has been estimated at 75% (57).
Soy protein isolate. Isolates are made by extracting unheated
defatted soy flakes with mild alkali (pH 7-8.5). The extract is acidified to
pH 4.5 (isoelectric point of the major soy proteins) to precipitate the
protein. The protein is then washed and either ground to form isoelectric
isolate, or neutralized and ground to form neutral isolate. Isolates are ca
96% protein with ash forming most of the remainder. The procedure is
approximately 60% efficient in terms of total protein recovery. The more
complex processing results in greater costs for isolates than flours or
concentrates. The increased cost of an isolate does not necessarily
translate into improved calf performance. Because of increased costs
without reliable benefit, soy isolates are seldom used in milk replacers.
Ethanol treated soy flour. Fukushima (24) showed that soy products
were denatured by heating with aqueous ethanol. Apparently the
hydrophobic centers of the globular protein molecules become exteriorized,
altering the protein configuration and stability. Aqueous ethanol extraction
can be used to eliminate the antigenicity of soy proteins (85). The ability of
ethanol extraction to inactivate antigenic factors was questioned by others
(6,7) who continued to find immune hypersensitive reactions. Subsequently,
it was found that processing conditions, such as ethanol concentration,
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temperature and duration of extraction were critical in determining the
efficacy of the process (81). Use of ethanol extracted, non-immunogenic soy
flour in milk replacer results in calf performance superior to soy
concentrate but inferior to milk protein (79,85).
Enzyme treated soy products. It has been shown that peak activities
of protease in gastric and pancreatic secretions of preruminant calves are
not achieved until 1 month of age (28,29,10*). Sissons <3c Thurston (82)
reported that in vitro pepsin digestion destroys the antigenic activity of
glycinin, but not that of (3-conglycinin, while trypsin has little effect on
either protein. In the belief that the calves digestive system could be
augmented by the use of exogenous enzymes, both supplementation and
pre-digestion by enzymes has been tried. The addition of pepsin to milk
replacer containing soy proteins failed to improve calf performance (23,47).
Digestion with individual enzymes or combinations of enzymes, prior to
feeding, failed to improve soy flour-based milk replacer (16,23).
Acid/Alkaline treated soy products. Incubating a "fully cooked" soy
flour at pH k or pH 10.6 for 5 hr at 36°C improved the product for use in
milk replacer (16). A similar improvement was found with a thermo-alkaline
treatment (pH 10.5, 85 °C, 5 min;15). Careful control of conditions during
heating is needed to prevent methionine loss or the production of toxic
peptides (15). Though these products proved superior to the pretreated
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forms of soy flour, they remain inferior to milk protein for use in milk
replacer.
Thermoplastically extruded soy products. Thermoplastic extrusion, or
simply extrusion processing can use any of the aforementioned soy products
as a raw material. When using the more basic soy flours a comparatively
inexpensive end product can result. Thermoplastic extrusion works by the
interaction of temperature, pressure and the large shear forces exerted
upon material being forced through the extruder barrel. There is an
approximate knowledge of the gross physical conditions within an extruder,
while the microenviroment and the chemical reactions of the substrate
within the barrel of an extruder are largely unknown. Studies of the effects
of extrusion have largely been of an empirical nature. The majority of
research effort in this field has been devoted to the study of texturing soy
proteins for human consumption. Hamdy (31), in a review of the human
nutritional aspects of textured soy products, concludes "under the
moist
-heat -pressure conditions of processing textured soy proteins,
antimetabolites in soybeans are inactivated to have practically no effect on
the latter 's nutritive value". In respect to the calf, texturing is not of
direct interest; however, the reactions of the process are of interest. The
fact that a major portion of the total protein in soybean is allergenic to
the calf prevents removal of this antimetabolite from being a viable method
of processing. An alternative is to modify the proteins such that they have
different biochemical activities. The change in physical properties during
19
texturing reflects a change in the structure and therefore the biological
activity of the proteins. Thus, extrusion offers the possibility of a product
with a similar amino acid profile to raw soybeans, while having a different
biochemical activity. Little is known about the potential for extruded soy
products in milk replacer. Srihara (88) showed an extruded soy flour to be
superior to a heated soy flour, but inferior to milk protein, when used in
milk replacers for calves.
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EXPERIMENT 1
SOY PROTEIN CONCENTRATE, COMMERCIAL HEATED SOY FLOUR AND
AN EXPERIMENTAL SOY FLOUR AS PROTEIN SOURCES IN MILK
REPLACERS FOR CALVES.
ABSTRACT
Metabolic, physiological and immunological parameters were
monitored in preruminant calves fed one of four milk replacers. Protein
sources for the milk replacers were all milk (AM) or 25% milk protein and
75% protein from either soy protein concentrate (SPC), commercial soy
flour (CSF) or experimental soy flour (ESF). The experimental soy flour had
trypsin inhibitor activity of <1 unit/mg. Using the nitrogen retained at 3
and 6 wks, the presence of abnormal intestinal mucosa, growth rates and
the development of circulatory immunoglobulins specific to soy proteins, the
three soy-based milk replacers were inferior to the AM milk replacer. The
soy-based diets induced a marked antibody-mediated allergic response in the
calves, with no major difference in this response between soy products.
There was no cell-mediated immune response to any of the soy products.
Calves showed improved performance with age, particularly on the
soy-based diets. Milk replacers SPC and ESF gave comparable calf
performance, both being superior to CSF.
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INTRODUCTION
The cost of production and the value of milk as a human food makes
its use as animal feed relatively expensive. The vulnerability of the young
calf to stress and its reliance upon liquid feed presents a difficult problem
to those looking to provide an alternative to milk. Protein is the major cost
ingredient of a milk replacer and it has proved difficult to find a
satisfactory alternative source to milk. Soybean protein has potential for
use in a milk replacer and has received much attention. It is recognized
that commercial soy flours and protein concentrates require further
processing to inactivate antinutritional factors prior to their intensive
inclusion in high quality milk replacers for calves. It has been shown that
trypsin inhibitor (TI) inhibits the activity of bovine trypsin (20). The
reduced proteolytic activity probably contributes to the poor digestibility of
soy proteins in the young calf.
The objectives of this study were to use metabolic, growth, health
and immunological responses of calves to determine the relative quality of
four milk replacers. The milk replacers differed mainly in the source of the
major portion of protein. In effect the objective was to compare milk,
heated soy flour, soy protein concentrate and an experimental moist heat
processed soy flour as protein sources in calf milk replacer. The
experimental soy flour received moist heat treatment sufficient to reduce
TI activity <1 TI unit/mg.
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MATERIALS AND METHODS
Management of calves
Eight Holstein bull calves, 2 per treatment, housed in metabolism
crates, were used to measure nitrogen balance and xylose tolerance at 3
and 6 wks of age and intestinal morphology at 6 wks of age. A further 24
calves, 6 per treatment, housed in hutches, were used from birth through 6
wks to monitor growth and immune reactions.
All calves received colostrum for 3 days after birth. Treatments were
assigned to calves by randomized block, a block being the k treatment
diets. The appropriate milk replacer was fed warm, by pail, half in the
morning, half in the afternoon. No dry feed was given, water was available
ad libitum. Calves in metabolism crates had no bedding and were housed in
a temperature controlled room. The remaining calves were housed outdoors
in individual hutches and bedded on straw.
Each calf was twice daily assigned a value for general appearance
(good, fair or poor) and consistency of feces (1, normal, through 4,
watery)(46). No treatment for scours was necessary during the trial.
Milk replacers
The ingredient composition and nutritional composition of the milk
replacers are shown in Tables 1 and 2, respectively. The four milk replacers
were similar in all aspects except the source of the major portion
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Milk Replaicer
iem AM SPC CSF ESF
(%)
Spray dried whey 19.32 16.25 16.00 16.00
Whey protein concentrate 48.25 • •• • •• • ••
Soy protein concentrate
Commercial soy flour
• •• 26.25 •• • ••
••• • • • 33.15 • • •
Experimental soy flourc • •• • •• • •• 33.15
L-Lysine >•• .02 • *• • ••
DL-Methionine
••• .04 • •• • ••
Lactose ,
••• 22.51 15.92 15.92
10/50 Fata 31.25 33.75 33.75 33.75
Limestone
.63 .63 .63 .63
Na mineral premix
.50 .50 .50 .50
Chloratetracycline 100 .05 .05
LU./
.05
Fi-r
.05
Kg
Vitamin A 33069 33069 33069 33069
Vitamin D 6613 6613 6613 6613
Vitamin E 200 200 200 200
Procon, A.E. Staley Manufacturing Co., Decatur, IL 62526.
Lauhcff soy flour (50%), Lauhoff Grain Co., Danville, IL
'Experimental soy flour «1 unit T^mg) see text.
10/50 Made from fat (50%), dried whey (45%), and caseinate (5%)
and contains 10% protein and 50% fat.
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TABLE 2. Nutrient composition of milk replacers.
Milk Replacer
£em AM SPC CSF ESF
(%) of DM
Protein (N X 6.25) 21.98 22.56 21.98 21.98
Lipid 17.26 17.11 17.35 17.35
Ash 7.01 4.14 4.82 4.82
Calcium 1.07 .62 .64 .64
Phosphorus
.68 .32 .52 .52
Lysine 2.06 1.62 1.54 1.54
Methionine
.41 .45 .33 .33
of protein. Diet A M was a positive control for the soy based irulk replacers,
with all of its protein being milk protein. The three remaining diets each
had 25% of their protein derived from milk and 75% from either soy protein
concentrate (SPC), commercial heated soy flour (CSF), or an experimental
soy flour (ESF). The experimental soy flour was prepared by steam heating
(100°C) 9 kg batches of dehulled, defatted, raw soy flakes, with 10% added
moisture, far 60 min. The "cooked" soy was dried overnight in a forced air
oven (50° C) before grinding. The resultant product had TI activity of <1
unit/mg. TI activity was measured using the method of Ramsey and Willard
(67).
Milk replacer was given at 1.25 kg DM/100 kg body weight, fed as a
12.8% solution for the first 2 wks and 1.75 kg DM/100 kg body weight, fed
as a 17% solution thereafter. The amount of milk replacer fed was adjusted
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weekly. If a calf lost weight, milk replacer was fed at the level appropriate
to the weight before such loss.
Nitrogen retention
The percent nitrogen retained by calves kept in metabolism crates
was monitored over the last 72 hrs of wks 3 and 6. Urine and feces were
collected together in tubs placed below the metabolism crates, into which
25 ml of concentrated sulfuric acid had been placed. Collections were made
over three consecutive 24 hr periods. The material collected was thoroughly
mixed before a 1% subsample was taken and frozen. Subsamples from
consecutive 24 hr periods were pooled to give the sample for one calf for
that collection period. The nitrogen content of both feeds and excreta were
measured using standard macro-kjeldahl procedures (3). Percent nitrogen
retained by the calf was calculated as the nitrogen fed minus nitrogen in
excreta expressed as a percentage of the nitrogen fed.
Xylose tolerance.
Following the nitrogen collection periods, calves in metabolism
crates uderwent xylose absorption studies. D(+)-xylose does not normally
occur in any significant amount in blood and urine, is not degraded in the
intestine and is apparently absorbed by diffusion (87). Following oral
ingestion of xylose the observation of a low level of xylose in the blood and
urine is considered indicative of a defect in the absorptive function of the
small intestine (87). The method involves omission of an afternoon and
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morning feeding before oral administration of 0.5 g D(+)-xylose/Kg body
weight as a 10% solution. Jugular blood was sampled before and hourly for
5 hr after xylose administration. Blood samples were refrigerated overnight
before serum was collected and frozen until analyzed for xylose content.
Urine was collected during the 5 hrs following xylose administration and a
quantitative sample frozen until analyzed for xylose content. Xylose
content of samples were measured using the method of Henry (32).
Intestinal morphology
One of the symptoms of an allergic response to ingested items is
atrophy of the intestinal villi. At the end of 6 wks, calves from the
metabolism crates were euthanized and sections taken from the duodenun
(10 cm distal to the pylorus), jejunum (220 cm distal to the pylorus) and
middle of the small intestine. Samples were preserved in 10% buffered
formalin before being viewed using light and scanning electron (SEM)
microscopes, according to the methods of Seegraber and Morrill (76).
Serum antibodies to soy proteins
Blood samples were obtained from calves in hutches on the day a
treatment was assigned and weekly thereafter. The serum was frozen until
analyzed for anti-soy immunoglobulins. Following the recommendations of
Pitts et al. (62) an enzyme linked immuno-sorbent assay (ELISA) method was
used to find the levels of serum immunoglobulin G (IgG) specific to the
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soybean proteins glycinin and fl-congLycinin. The immunogenic soy proteins
were extracted and purified by the mathcd of Thanh and Shibasaki (93).
The ELTSA procedures used in this experiment were as given below.
a) The wafls of microtitre plates were used as the solid phase and
coated with purified glycinin or fl-conglycinin, by incubating 200 ul/well of
a solution of 100 ug protein/ml in carbonate buffer (pH 9.6) for 1 hr at
37°C.
b) Plates were washed 3 times, using phosphate buffered saline (PBS)
containing 1% bovine serum albumen (BSA), to remove unbound soy protein.
c) The fluid from the last wash was left in the wells and incubated
for 30 min. at 37°C (this was to allow the BSA to bind to and thereby block
any areas of the solid phase not occupied by the soy protein antigens).
d) Serum samples from experimental calves were diluted 1:200 in PBS
with 0.5% BSA and 0.1% tween 80 (solution W). After removing the blocking
fluid, diluted serum was added (200 ul/well) to each of three antigen coated
wells. Plates were incubated for 1 hr at 37° C, to allow serum antibodies
specific to the soy protein to bind to the antigen.
e) Plates were washed 3 times with solution W, to remove unbound
antibodies.
f) 200 ul/well of peroxidase labeled, affinity purified, goat
Dynatech laboratories Inc. 900 Slaters Lane, Alexandria, Virginia.
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2
antibovine IgG
, at 1:2000 in solution W, was incubated for 1 hr at 37°C
(the peroxidase labeled goat antisera reacts with the EjG from the test
serum to form a solid phase-antigen-antibody-peroxidase labeled complex).
g) Plates were washed 3 times with solution W, to remove unbound
goat serum.
h) 200 ul/well of peroxidase substrate [0.012% H
2 2,
0.0001%
2-2-Azino^(3-ethyl-benzthiazaline sulfonic acid) (ABTS) in 0.045% Citrate
buffer, pH4] was added and incubated for 30 min. at 37°C (the enzyme and
substrate react giving a colored end product).
i) The optical density of each well was measured at 405 nm.
Optical density is positively correlated to anti-soy antibody
concentration in the test serum.
A positive control (serum from a calf given intramuscular injections
of glycinin and fl-conglycinin homogenized with Freund's complete adjuvent),
a negative control (fetal calf serum), and a blank (PBS) were run with each
plate.
2 .
Karkegard and Perry Laboratories Inc., 2 Cessna Court, Gaithersburg, MD
20879.
3 .
Biotek EIA Reader, Model EL 307, Biotek Instruments Inc., Highland Park,
Box 998, Winooski, VT 05404.
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Cell-mediated immune response
Jugular blood collected in hepannized tubes from two calves per
treatment was used within the hour following collection. 2 ml of blood
mixed with 2 ml of phosphate-buffered saline (PBS) were layered on 4 ml of
Histopaque-1077^ containing ficoll and sodium diatrizoate, then centrifuged
at 400 X g for 30 min. Lymphocytes sedimented at the interphase were
collected with a pasteur pipette, washed twice with RPMI-16405 medium
and resuspended in RPMI-1640 containing 25 mM Hepes buffer and 10*
fetal calf serum (FC5). Cells were counted in a hemocytometer, and the
suspension adjusted to contain IX 105 cells/ml. The cell suspension lacking
or containing various concentrations of glycinin or B-conglycinin was
distributed (200 ul/well) in quadruplicate in a flat bottom tissue culture
plate. Cultures were incubated at 37°C in a humidified carbon dioxide
incubator. Viability of lymphocytes was >95% during the course of the
experiment as determined by trypan blue dye exclusion test. After 48 hr of
incubation 0.2 uCi/culture tritiated thymidine6 was added (specific activity
6.7 Ci/mM). Cultures were harvested 24 hr later on glass fiber filters in an
automated cell counter 7
.
Filters were counted in a liquid scintillation
if.
Sigma Chemical Co., St. Louis, MO 63178
Grand Island Biological Co., Grand Island, NY 14072
Schwarz/Mann, Dickinson and CO., Orangeburg, NY 10962.
PHD Cell harvesting system, Cambridge Technology, Cambridge, MA.
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counter 8 to determine the incorporation of labeled thymidine in
lymphocytes. Lymphocyte stimulation indices (LSI) were calculated as: LSI =
Disintegrations per minute (DPM) of stimulated lymphocyte cultures/DMP of
control cultures.
Cutaneous immune response
At 6 wks, after the final serum sample for ELISA had been taken, all
calves were given intradermal injections of purified proteins. Calves were
prepared by shaving the hair from an area of white skin and 1 mg of
purified protein was injected as a 2 mg/ml emulsion. Proteins injected were
glycinin, (J-conglycinin, bovine serum albumen and whey, each at a separate
site. The first two are the soybean proteins shown to elicit an allergic
response in the calf, while the latter two were negative controls. The sites
of injection were observed for swelling, frequently during the first hour,
hourly to 6 hrs and once the following morning.
Statistical analysis
Data were analyzed using statistical analysis system's (SAS) general
linear models (GLM) procedures (72), where the four diets were the
treatments. Treatments were blocked by time started on experiment and
with birth weight as a covariate.
T-S 6800 Model, Beckman Instruments Inc., Fullerton, CA 92634.
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RESULTS AND DISCUSSION
Calf growth.
Mean weekly weights for the k treatment groups are in Figure 1.
Calves given diet AM gained more weight in the first 3 wks than calves on
the soy diets. This early weight advantage was maintained to the end of the
experimental period at 6 wks. Among the soy diets, the SPC group gained
weight during the first 2 wks, while the ESF and CSF groups lost weight. In
the third week the ESF group did show compensatory growth sufficient to
equal and continue to equal the SPC group. Calves are particularly
susceptible to stress during the first few weeks. If the inferior response in
the first 2 wks of calves on ESF, compared to SPC, proved to be
consistent, it would be grounds for choosing SPC over ESF. In weeks 4, 5
and 6 the rates of gain for the AM, SPC and ESF groups were similar,
though the actual weights of the AM group remained higher. Though the
CSF group gained weight in the last k wks it did so at a rate slightly lower
than the other groups.
Nitrogen retention.
Nitrogen retention by calves as a percent of nitrogen fed is shown in
Table 3. Calves fed diets SPC and ESF had superior nitrogen retention to
calves on the CSF diet, but inferior nitrogen retention to the AM calves;
this was true at both 3 and 6 wks. All 4 treatment groups showed
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Figure 1. Growth of calves fed milk replacers with all milk (AM) protein, or
with 70% of the protein from soy protein concentrate (SPC);
commercial heated soy flour (CSF>, or an experimental heated soy
flour (ESF). Values are the mean for five calves per treatment,
different superscripts denote significant differences (P<.05)
within a week.
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TABLE 3. Nitrogen retained by calves at 3 and 6 weeks of age.
Milk % Dietary nitrogen retained
replacer 3 weeks 6 weeks
AM 47.0 - .2 61.5 - 2.3
SPC 30.3 - 1.4 51.1 - 2.1
CSF 22.5 - b 38.2 - 8.1
ESF 33.0 - 11.1 46.5 - 1.5
Mean of two calves — SE.
Data from one calf only.
improved dietary nitrogen retention when calves were 6 wks old, compared
to 3 wks old, this is thought to reflect maturation of the digestive system.
Calves receiving the all milk protein milk replacer (AM) showed relatively
small improvement in nitrogen retained with aging. The small improvement
with diet A M was due to the initial nitrogen retention being relatively high,
leaving little room for improvement. In calves receiving a soy-based diet,
development of a gastro-intestinal immune response acted against
improvements in digestibility due to the maturing digestive system. One of
the symptoms of a food allergy is reduced absorption of nutrients. Calves
on diets SPC and ESF showed greater improvement in nitrogen retained
with age than calves on either diet AM or CSF. The relatively small
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improvement in nitrogen retained by calves on the CSF diet may have been
associated with a more severe immune reaction.
Serum antibodies to soy proteins.
The mean serum IgG levels specific to the soy proteins glycinin and
B-conglycinin are illustrated in Figures 2 and 3, respectively. There was a
marked elevation in soy directed antibodies in all soy-fed groups by the
third week on trial. Elevated serum antibodies specific to a protein is a
strong indication of an allergic response. The AM group maintained their
anti-soy antibodies at a level similar to that in the initial pre-trial serum
samples. There were statistically significant differences in the antibody
response between soy-fed groups. The differences between soy diets are not
consistent between the two antigenic proteins and may not represent
biologically significant differences in the calves response. It is possible that
the different processing given the soy products resulted in different
activities of the two antigens.
Ceil-mediated immune response.
We did not detect a cell -mediated immune reaction to either glycinin
or 13-conglycinin, as determined by in vitro lymphocyte stimulation. This
method is relatively sensitive to mitogenic activity, suggesting that there
was no significant cell-mediated immune response in the calves tested. It
remains possible that a cell-mediated immune response may occur in some
cases, but it seems not to be a general response.
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Figure 2. Serum antibodies (IgG) to the soy protein glycinin in calves fed
milk replacers with all milk (AM) protein, or with 75% of the
protein from soy protein concentrate (SPC); commercial heated
soy flour (CSF); or an experimental heated soy flour (ESF). Values
are the mean for five calves per treatment, different superscripts
denote significant differences (P<.05) within a week.
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Figure 3. Serum antibodies (IgG) to the soy protein 13-conglycinin in calves
fed milk replacers with all milk (AM) protein, or with 75% of the
protein from soy protein concentrate (5PC); commercial heated
soy flour (CSF); or an experimental heated soy flour (ESF). Values
are the mean for five calves per treatment, different superscripts
denote significant differences (P<.05) within a week.
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Cutaneous immune response.
The cutaneous injection of purified proteins failed to induce any
detectable immune response, with one exception. One calf on diet ESF
developed severe scours and lost weight during its late second and early
third week on trial. Because of its weak condition the calf was removed
from the experiment after 17 days. This calf was subsequently given diet
AM and rapidly improved in condition. One week after being taken off
experiment it was given cutaneous injections of glycinin and 13-conglycinin
in the same manner as the other calves. By k hrs after the injections a
clear swelling had developed in response to both glycinin and B-conglycinin.
The swelling was indicative of IgG mediated, type III hypersensitivity. That
there was a systemic IgG response to the soy diets is indicated by the
serum ELISA results. It seems that this cutaneous test has insufficient
sensitivity to detect this IgG mediated response in most cases. It is possible
that there was some additional component to the immune response in this
one calf that caused its exceptional severity. Severe responses to soy
proteins by a minority of calves have been reported by others (7,67). It is
not uncommon to have an immune reaction confined to either the humoral
or cell-mediated immune system. It appears that the calf, unlike the mouse
and piglet, does not have a cell-mediated component to this dietary
intolerance.
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Intestinal morphology.
Observations of the small intestinal mucosa indicated some villous
atrophy in calves receiving diets containing soy protein. Villous atrophy was
not as severe as noted in some studies (76,80) and there were no marked
differences between the three soy diets. No detailed microscopic analysis of
the tissues was done and there may have been minor differences between
the soy groups. Calves receiving diet AM had comparatively normal villi.
Fecal consistency.
The mean weekly fecal scores are in Figure k. The AM group had the
softest feces for the first 2 wks and the driest for the last k wks. It was
unexpected for the AM fed group to have looser feces at any time. It may
be that the higher level of whey minerals in the AM diet (diet composition
Table 2) resulted in the soft feces. The reduction in fecal score by week 3
may reflect adaptation to these levels of whey. Work by Bush et al. (11)
indicates calves adapt to high levels of whey in their diet within 2 wks. All
treatment groups showed an increase in fecal score from the first to second
week. This was due mainly to the low fecal score in the early part of the
first week as calves excreted their colostral feces. From the second week
on to the end of the experimental period all treatment groups showed a
decrease in fecal score, presumably due to adaptation to the feeding regime
and maturation of the intestine. The C5F group showed the least
improvement in fecal score; this may reflect a more severe effect of this
diet on calves.
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Figure 4. Fecal score (l=narmal, 4=watery) of calves fed nullc replacers
with all nulk protein (AM), or with 75% of the protein from soy
protein concentrate (SPC); commercial heated soy flour (CSF);
or an experimental heated soy flour (ESF). Values are the mean
of five calves per treatment, different superscripts denote
significant differences (P<.05) within a week.
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wXylose tolerance.
The percent urinary xylose clearance by calves over 5 hrs following
administration are in Table 4. Serum xylose concentrations for the 5 hrs
following oral xylose administration are illustrated in Figures 5 and 6 for
wks 3 and 6, respectively. We expect absorptive capacity to be positively
correlated with calf performance. Based on other results in this trial the
AM group was expected to have the greater absorptive capacity and the
CSF group the least. In fact, the SPC fed calves had significantly higher
blood xylose concentrations at both 3 and 6 wks, with no difference among
the other three treatment groups. There were no significant differences in
urinary xylose concentrations. These results suggest the SPC group had
TABLE 4. Percent of oral xylose dose excreted in urine in five hours.
Milk Urinary xylose: % of dosea
Replacer 3 weeks 6 weeks
AM 10.8 ± 1.7 17.2 ± 7.6
SPC 5.8 i 2.0 15.6 ±4.9
CSF 7.2 ± 3.4 8.9 ±1.1
ESF 8.4 ± 1.3 9.8 ±3.9
Mean of two calves ± SE.
<u
Figure 5. Serum xylose concentration following oral administration of
.5g
xylose/Kg body weight in 3 wk old calves fed milk replacers
with all milk (AM) protein, or with 75% of the protein from soy
protein concentrate (SPC); commercial heated soy flour (CSF);
or an experimental heated soy flour (ESF). Values are the mean
of two calves per treatment, different superscripts denote
significant differences (P<.05) at a sample period.
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Figure 6. Serum xylose concentration following oral administration of .5g
xylose/Kg body weight in 6 wk old calves fed milk replacers with
all milk (AM) protein, or with 75% of the protein from soy protein
concentrate (SPC); commercial heated soy flour (CSF); or an
experimental heated soy flour (ESF). Values are the mean of two
calves per treatment, different superscripts denote significant
differences (P<.05) at a sample period.
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superior absorptive capacity to the other groups and is contrary to other
parameters of calf performance we measured. No satisfactory reason was
found for this, though it is noted that the xylose absorption method has
been found unreliable in detecting food allergies (32).
SUMMARY
In this experiment, utilization of milk replacers improved as calves
aged, particularly over the first three weeks. This phenomenon is
compatible with the theory that a neonatal calf has an immature, but
developing digestive system. The improvement in performance on the
soy-based diets was greater than that seen on the milk-based diet, mostly
because the soy based diets were notably inferior for calves <3 wks of age.
Performance of calves on the all milk protein was superior to that on soy
•protein concentrate and experimental soy flour which in turn were superior
to the commercial heated soy flour. All soy-fed groups had a humoral, but
no cell-mediated immune reaction to soy proteins. An alternative method of
processing has to be found before soy can be used as the major protein in a
quality milk replacer for young calves.
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EXPERIMENT 2.
THERMOPLASTIC EXTRUSION PROCESSING OF SOY FLOUR FOR USE AS
A PROTEIN SOURCE IN MILK REPLACER FOR CALVES.
ABSTRACT
Enzyme active soy flour was used as the starting material for
thermoplastic extrusion processing. Five processing conditions were varied
in a 5 X 2 factorial arrangement, resulting in 32 products. AH extrusion
products had >90% reduction in trypsin inhibitor (TD activity. The extrusion
products had a wide range of antigenic (glycinin and 8-conglycinin)
activities; these were not closely related. Only one product had no
detectable activity far both glycinin and fl-conglycinin. This "antigen free"
extrusion product had very low TI activity (1 unir/mg) and was used as the
major protein source (70%) in three experimental milk replacers. The effects
of amino acid supplementation and acidification of milk replacers based on
the extruded soy were also studied. Metabolic and growth response of
calves were used to compare the experimental milk replacers with an all
milk protein control in an in vivo study. The extruded soy was inferior to
milk as a protein source for nulk replacers. A A supplementation of soy was
detrimental to calf performance. Acidification of soy based milk replacer
had some benefit in the young «3 wks old) calf, but was not beneficial
later.
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INTRODUCTION
There have been many studies to find an inexpensive yet high quality
alternative to milk as a protein source in liquid calf feed. To date such
studies have been partially successful, manufactures being able to replace a
minor portion of the total protein.
There has been considerable research into the use of thermoplastic
extrusion as a means of texturing soy proteins for human consumption.
Extrusion can alter the physical and biochemical properties of a protein
without detriment to its nutritional value. Human studies have concentrated
on physical modification of the soy proteins to provide meat analogues. The
calf, however, requires modification of the biochemical properties of soy
proteins to inactivate antinutntional factors. Because of the different
requirements of the end product, much of the work on soy extrusion to date
is of limited value to the calf. One area where human orientated extrusion
research might be of use would be in identifying processing variables having
a marked effect on the end product.
The aim of this study was to examine the effects of thermoplastic
extrusion on the suitability of soy flour as a protein source for calf milk
replacer. Trypsin inhibitor and antigenic glycinin and B-conglycinin were
monitored in extrusion products. The extrusion product with the lowest
activity of these antinutntional factors was tested as the major protein in
three experimental milk replacers. Calf health, growth and nitrogen
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retention were measured. Also, the effects of amino acid supplementation
and acidification of the soy diet were evaluated.
MATERIALS AND METHODS
Extrusion processing
9Enzyme active soy flour was chosen as the raw material for
extrusion processing. This product is oil-extracted, desolventized soy flour,
without additional heat treatment. A Wenger X-20 Extruder was used
throughout the experiment. Processing parameters changed were
temperature, moisture, ionic concentration, pH and sulfur concentration.
There were 32 treatments produced by arranging the processing variables in
a 5 X 2 factorial arrangement. To minimize the number of barrel
temperature changes (a relatively slow process to stabilize) extrusion
processing was carried out over two consecutive days; high temperature
combinations on one day and low temperature combinations the next. Barrel
temperature was maintained at a relatively high or low temperature, within
the range at which a stable product could be obtained, approximately 140°C
and 80°C, respectively (temperature measured at the seventh/last head).
Similarly, the quantity of steam added to the soy flour in the barrel was
changed from a large amount to a small amount, within the range at which
a stable product
9
Industrial Grain Products, Saint Joseph, Mo.
10„Wenger Mixer MFG., Sabetha, Kansas.
k7
could be obtained, approximately 25% and 19% moisture, respectively
(moisture of product at the die). Ionic concentration was Changed in half
the treatments by the addition of 2% CaO'2H O. Calcium chloride was
chosen as the modifier of ionic concentration because of its subsequent
potential as a calcium source for the calf. Calcium chloride was added at
2% because this concentration had been shown to be optimal in some
textural studies (personal communication, J. Huber, Wenger MFG, Sabetha,
Kansas). The pH of the soy flour was reduced in half the treatments by the
addition of 3% fumaric acid. An organic acid was chosen because of its
potential nutritional value to the calf. Fumaric acid was chosen from among
the three most common organic acids, because it was less expensive, it is a
stronger acid than citric and lacks the unpleasant odor of butryic. We
added 3% fumaric acid, this being the amount needed to bring a solution of
the soy flour to approximately pH 4.2, the isoelectric point of soy protein.
The presence of organic sulfur is thought to affect the secondary structure
of the extruded proteins by the formation of disulfide bonds. Thus, 0.19%
organic sulfur was added to half the samples before extrusion. This
concentration of sulfur had been shown to be optimal in some textural
studies (personal communication, 3. Huber, Wenger MFG, Sabetha, Kansas).
For each set of extrusion conditions as soon as the product at the die
appeared stable a sample was taken to determine dry matter at the die. A
second sample was air dried and used to find dry matter, TI and antigen
activities.
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On the basis of the in vitro tests, one set of processing conditions
was chosen to produce the material for the in vivo test. Sufficient material
was produced to provide 70% of the protein in three soy-based experimental
milk replacers. Before being used in the diets this second extrusion product
was tested in vitro for antinutritional factors.
Antinutritional factors
Trypsin inhibitor. TI activities of the 32 products were tested by the
method of Ramsey & WiUard (67).
Antigens. The activities of the recognized antigens (glycinin and
S-conglycinin) were measured in the 32 products, using the procedures
below.
The immunogenic soy proteins were extracted and purified by the
method of Thanh and Shibasaki (94). Using these purified proteins, antisera
were developed in rabbits. Four New Zealand White rabbits, 8-10 weeks of
age, were injected intramuscularly, or into the foot pad, with 2 mg
solutions of either glycinin or 8-conglycinin homogenized with Freund's
complete adjivant. Three of these injections were given at 2 wk intervals.
A week after the final injection, approximately 50 ml of bleed was
collected from the ear vein of each rabbit and the serum frozen until
purified. Rabbit serum proteins were purified by ammonium sulfate
precipitation, by the method of Garvey et aL (25). Approximately half of
the purified antisera were frozen until used in the ELBA assay. The
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remaining antisera were conjugated to horse radish peroxidase by the
method of Nakane and Kawaoi (53) and frozen until used in the ELBA
assay. Extracts of the experimentally processed soy flours were prepared by
extracting 3.0 g of each ground extruded product with 25 ml 0.9% NaCl for
1 hr, at pH 6.7. Soluble proteins were recovered by centrifugatLon.
Enzyme linked immuno-sorbent assay (ELBA) procedure a) The wells
of microtitre plates11 were used as the solid phase and coated with purified
rabbit antisera to glycinin or 8-conglycinin. Plates were coated by
incubating 200 ul/well of antisera, diluted 1:50 for glycinin or 1:100 for
fl-conglycinin in carbonate buffer (pH 9.6) overnight at 4°C.
b) Plates were washed 3 times, using phosphate buffered saline (PBS)
with 0.1% Tween 20 (solution Y), to remove unbound antisera.
c) The soy extracts to be tested were diluted to 1:25 for glycinin and
1:50 for fl-conglycinin, in solution Y. Diluted extract (200 ul/well) was
added to the antisera coated wells, 3 wells per sample. Plates
were incubated overnight at 4°C, allowing the soy antigens to
complex with the appropriate bound antibody.
d) Plates were washed 3 times with solution Y, to remove unbound
soy protein.
e) Peroxidase labeled rabbit antiglycinin cr antifl-conglycinin
Dynateck Laboratories Inc., 900 Slaters Lane, Alexandria, Virginia.
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antibody was added (200 ul/well) as appropriate, diluted 1:100 in solution Y
and incubated far 1 hr at 37°C.
f) Plates were washed 3 times with solution Y, to remove unbound
conjugate.
g) Peroxidase substrate [0.012% H
2
0_, 0.0001%
2-2-Azino^(3-ethyl-benzthiazoline sulfonic acid) (ABTS) in 0.045% Citrate
buffer, pH4] was added (200 ul/well) and incubated for 30 min. at 37°C (the
enzyme and substrate react giving a colored end product).
12
h) The optical density of each well was measured at 405nm . Optical
density is positively correlated to soy antigen activity in the test extract.
A positive control (extract from enzyme active soy flour), a negative
control (whey protein extract), and a blank (PBS) were run with each plate.
Experimental milk replacers
On the basis of the TI and antigen assays, one of the 32 extruded
products was chosen as a protein source for three experimental milk
replacers, for use in an in vivo study. The extrusion product chosen was
processed with high moisture, high temperature, high ionic concentration,
high sulfur concentration and low pH. The antigenic activities of glycinin
and S-conglycinin were zero and TI activity was 1 unir/mg.
Four milk replacers were prepared differing as follows: MRl, a
12 .Bwtek EIA reader, Model EL 307, Biotek Instruments Ihc, Highland
Park, Box 998, Winocski, VT 05404.
51
positive control with all milk protein; MR2, 30% of the total protein from
milk and 70% from the extruded soy flour; MR 3, similar to MR 2, except
1.4% of the protein was supplied by methionine (0.7%) and lysine (0.7%)
rather than irulk protein; MR4, similar to MR3, except for the addition of
1% citric acid. The milk replacers were formulated to have 22% protein (N
X 6.25), 20% lipids, 0.95% calcium, 15909 IUAg vitamin A, 3409 EJAg
vitamin D^ and 9.09 JUAg vitamin E. Ingredient composition of the milk
replacers are shown in Table 5.
nh vivo study
Management of calves. Eight Holstein bull calves, 2 per treatment,
housed in metabolism crates, were used to monitor nitrogen balance at 2, 4
and 6 wks. All calves received colostrum for 3 days after birth. Treatments
were assigned calves by randomized block, a block being the four treatment
diets. The appropriate milk replacer was fed warm, by pail, half in the
morning, half in the afternoon. The amount of milk replacer given was 1.25
kg DM/100 kg body weight, for the first 2 wks and 1.75 kg DM/100 kg body
weight thereafter. Milk replacer was given at 12.5% DM the first week,
13.5% DM the second week, 16% DM for weeks 3 and 4, and 18% DM for
weeks 5 and 6. The four increases in dry matter content of milk replacers
as fed over time were to avoid either large rapid changes in dry matter
concentration or excessively large volumes of milk replacer as the calves
gained weight. No dry feed was given, water was available ad libitum, and
the amount of miUc replacer fed was adjusted weekly. 2 a calf
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TABLE 5. Milk replacers: Ingredient composition.
INGREDIENT MILK REPLACER
(%) MRl
12.5
MR2 MR3 MR4
Spray dried whey
Whey protein concentrate 49.0 - - _
Extrusion product 16a - 32.5 32.5 32.5
Na Caseinate - 3.2 1.* 1.4
Skim milk 5.0 5.0 5.0 5.0
L-Lysine - -
.7 _
DL-Methionine _ -
.7 _
Lactose - 25.8 26.2 25.2
7/60 Fatb 31.5 31.5 31.5 31.5
Limestone
.5 1.0 1.0 1.0
Dicalcium Phosphate 1.0 .5 .5 .5
Mineral/vitamin premix
.5 .5 .5 .5
Extruded at high temperature and moisture, with high salt and
sulfur, and at low pH (see table 6).
7/60 A product containing 7% protein and 60% fat.
lost weight, milk replacer was fed at the level appropriate to the weight
before such loss. Calves had no bedding and were housed in a
temperature-controlled room.
Each calf was twice daily scored for general appearance (good, fair
or poor) and consistency of feces (Unormal, 4=watery)(46). No treatment
for scours was given during the trial.
Nitrogen retention
Nitrogen balance studies were carried out at the end of 2,4 and 6
weeks on trial. If for any reason a calf refused part of its milk replacer
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during car immediately before a nitrogen balance period then that period was
abandoned and an alternate nitrogen balance study was inserted the
following week. Excreted material was collected and analyzed as described
in Experiment 1.
RESULTS AND DISCUSSION
Extrusion processing
The 32 extrusion treatments are shown in Table 6. Some additional
processing data (rate of flow at the die and volume change) are given in
the Appendix. Some general trends were noted among treatments. It was
easier to obtain a stable extrusion product from those treatments with high
sulfur and they tended to farm a light puffy product. There was a slight
sulfurous odor/flavor associated with the extrusion of sulfur containing
treatments, becoming less noticeable on cooling. Addition of acid gave
extrusion products with a tangy taste.
Trypsin inhibitor
The enzyme active soy flour had a TI activity of 147.5 units/mg. The
levels of TI in the 32 extrusion products are shown in Table 6. All extrusion
treatments reduced TI activity >90% and several treatments eliminated
detectable TI activity. There were four extrusion products which retained
TI activities between 7 and 13 TI units/mg. This compares with 7-8 TI
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TABLE 6. Processing conditions and antinutrients of extrusion products
Acid
PROCESSING CONDITIONS
Temp. Salt Moist. Sulfur
ANTINUTRIENTS
Product Glycinin (5-Conglycinin
# 3%a
_
oCb
150
2%c
26.66
0.193; Tie A* A*
1
.033 .060
2 - 150 - 17.48 - - .02,7 .017
3 + HO - 26.58 - 7.1 .117 .041
* + HO - 18.07 - 3.2 .098 .021
5 - 140 + 24.76 - - .199 .038
6 - 140 + 20.82 - .6 .090 .012
7 + 150 + 24.76 - 11.8 .152 .050
8 + 130 + 23.76 - 6.9 .096 .026
9 - 125 - 26.40 + - .085 .058
10 - 110 - 19.85 + .3 .066 .010
11 + 125 - 24.73 + .5 .039 .013
12 + 118 - 19.48 + .6 .059 .038
13 - 123 + 25.35 + .2 .023 .063
14 - 115 + 19.12 + .4 .068 .025
15 + 135 + 26.45 + - .000 .026
16 + 118 + 20.97 + 1.0 .000 .000
17 - 75 - 25.57 - 1.5 .042 .032
18 - 80 - 23.75 - 1.4 .061 .064
19 + 98 - 24.26 - 3.7 .127 .129
20 + 90 - 25.80 - 12.2 .171 .018
21 - 80 + 23.14 - .3 .012 .000
22 - 95 + 21.31 - 1.2 .056 .128
23 + 115 + 22.67 - 5.1 .088 .021
24 + 120 + 18.05 - 2.8 .072 .000
25 - 75 - 26.28 + - .035 .040
26 - 85 - 19.68 + - .031 .042
27 + 75 - 24.84 + -
.034 .010
28 + 100 - 20.57 + 1.9 .003 .036
29 - 75 + 25.29 + 2.3 .022 .029
30 - 90 + 20.69 + 1.1 .032 .042
31 + 80 + 24.19 + 1.2 .046 .006
32 + 90 + 21.83 + .6 .043 .070
3% Fumaric acid.
"Temperature at the seventh/last extruder barrel head.
c2% Calcium chloride.
dMoisture at the die.
^Units of trypsin inhibitor activity per mg.
Absorption at 405nm, being proportional to antigenic activity.
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units/mg commonly found in commercial heated soy flours. It seems that
extrusion processing is capable of adequately reducing TI activity.
Antigens
The enzyme active soy flour had antigenic glycinin activity of 0.234
and antigenic B-conglycinin activity of 0.233, as measured by ELISA. The
ELISA results for the 32 extrusion products are shown in Table 6. The
activity of the recognized antigens (glycinin and B-conglycinin) remained
relatively high in some extrusion products. Most of the extrusion products
had markedly reduced antigenic activity of one or both of the antigens.
Three treatments gave extrusion products with no detectable activity for
one of the two antigens. Extrusion at high temperature, high moisture, high
salt, high sulfur and low pH gave a product with no detectable antigenic
activity for either antigen. This latter extrusion product had a low TI
activity (1 TI unit/mg) and was chosen as the protein source for an in vivo
study. The "antigen free" extrusion product was produced on a second
occasion using the same set of processing conditions. However, it is noted
that the first attempt at reproducing the "antigen free" extrusion product
failed. A possible reason for this failure lies in the mixing of the acid, salt,
sulfur and soy flour approximately 1 month prior to extrusion. It was found
that mixtures which contained acid developed a gritty texture on storage, it
may be that this change in some way affected the extrusion properties.
Thus, it is recommended that only freshly mixed material be used in this
type of extrusion processing. It should be noted that though extrusion
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appears to have inactivated the known antigens it remains possible for
there to be residual antigens not detected by the assay used. Also it is
probable that modification of the proteins has produced new antigens; these
may themselves be allergenic to the calf.
It seems that extrusion processing can inactivate the known soy
antigens, but that the processing conditions required are quite specific.
Further study would identify the effective range and optimal processing
conditions. Also the desirability of using sulfur in extrusion processing has
been questioned as its "possible" mode of action (fusion of the globular soy
proteins) may decrease protein digestibility. An alternative to sulfur may be
cystein, with its tendency to "open" globular proteins.
Calf health
There were several problems with calf health during the in vivo trial.
In the first treatment block the calf given MR3 developed a swollen right
knee. This calf suffered some discomfort and refused to drink milk replacer
on several occasions. During the second treatment block there was an
outbreak of infectious scours, some calves developed a more severe
infection than others, with the youngest calf (MR4) most severely affected.
Also in the second treatment block one apparently healthy calf on MR3
died after 3 wks; necropsy examination failed to determine the cause of
death. There was some refusal of soy based diets, though with the
exception of the calf with the swollen knee these were minimal. Several
soy-fed calves had considerable hair loss, while all soy-fed calves had some
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browning of the hair coat. The milk fed calves developed shiny coats
without hair Toss.
Calf growth
The growth of calves on the four itulk replacers is shown in Figure 7.
Young calves fed nulk replacer frequently have a quadratic growth pattern,
such was the case in this experiment. In the early phase (2-3 wks) calves
have an immature digestive system, small energy reserve and protein pool,
and are vulnerable to infection. The response of calves to milk replacer in
the first 2-3 wks is therefore of great importance. During the early phase
in this experiment (the first 2 wks) the iM Rl group gained the most weight,
the MR2 and MR4 groups had small weight gains, while the MR3 group had
a small weight loss. In the later phase (early phase to 6 wks) calves appear
to maximize their usage of a milk replacer, presumably due to improved gut
function. In this phase, performance differences between milk replacers
tend to be less pronounced, but are particularly important to operations
involving prolonged periods of liquid nutrition, i.e„ veal producers. In the
second phase the MRl group had a slightly higher growth rate than MR 2,
this in turn being higher than the MR3 and MR4 groups. The fact that
calves on MR3 had an inferior growth rate to calves on MR2 suggests that
supplemental lysine and methionine had a detrimental effect on calf
performance. A detrimental response to supplemental amino acids is not
unique and may be due to an amino acid imbalance (5). Calf growth on
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Figure 7. Growth of calves fed milk replacer with all milk protein (MR1), or
with 70% of the protein from an extruded soy flour (MR2);
extruded soy flour with supplemental amino acids (MR3); extruded
soy flour, acidified and with supplemental amino acids (MR4).
Values are the mean of two calves per treatment.
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MR3 and WW was similar, except during the second week. At this time the
MR* group was able to maintain its weight while both MR2 and MR3 groups
suffered a weight loss.
Fecal scores
Treatment means of the twice daily fecal scores are shown in Figure
8. Because of the variability of the data and the small number of calves
involved no clear treatment differences could be seen. One observation of
note was an apparent reversal of the trend to an increase in fecal score in
the second week by the MR* group, possibly associated with the selective
bacteriostatic effect of the lower pH.
Nitrogen balance
Nitrogen retention by calves at 2, * and 6 wks is shown in Table 7.
There were five occasions when a nitrogen balance could not be obtained at
the designated period (2, * or 6 wks). This was usually due to a calf
refusing part of its feed, either immediately before or during the nitrogen
balance period, disturbing the approximate steady state needed for this
test. Where possible, nitrogen retention was monitored the week following
the loss of a planned period. The first nitrogen balance period (2 wks) for
the second block of treatments coincided with an outbreak of infectious
scours. The three calves monitored at this time had a marked decrease in
nitrogen retained compared to the first treatment block. Because of the
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Figure 8. Fecal score (l=normal, 4=watery) of calves fed milk replacers
with all milk protein (MR1), or with 70% of the protein from an
extruded soy flour (M R2); extruded soy flour with supplemental
amino acids (M R3); extruded soy flour, acidified and with
supplemental amino acids (MM). Values are the mean of two
calves per treatment. *Data from one calf only.
3.5
3.0
2.5
UJ
O
o
<
CJ
HI
LL
2.0
1.5
1.0
£.
- MR1 - ALl- M |LK
o - MR2 - 16.
A- MR3 - 16 AA
• - MR4- 16 A A ACID
1 2 3 4 5
TIME ON EXPERIMENT (WEEKS)
6
61
TABLE 7. Percent dietary nitrogen retained by calves fed milk replacer.
MILK
REPLACER
TREATMENT
BLOCK
1
2
2
51.65
20.65
3
WEEK
4
67.15
66.14
5 6
MR1 67.63
57.35
Mean 36.15 - 66.65 67.63* 57.35*
MR2
1
2
7.02
-14.63
- 48.20
43.00 49.66
-
Mean
-3.81 - 45.60 49.66* -
MR3
1
2
0.90
43.48 _
52.46 51.16
Mean -0.90* 43.84* - 52.46* 51.16*
MR4
1
2
24.81
6.09 _
34.01
49.52 _
35.19
50.53
Mean 15.45 - 41.77 - 42.86
*
One c(bservation only
problems experienced, little significance can be attached to the nitrogen
balance data.
All treatment groups showed an increase in nitrogen retained after
the second week. The all milk protein group (MR1) had superior nitrogen
retention to the soy protein groups at all time periods. Among soy
treatment groups M R4 had superior nitrogen retention at 2 wks. This is
supportive of the fecal scores and growth of calves at this age in
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suggesting an advantage to the very young calf from acidification of the
milk replacer. Subsequent to 2 wks there was no major difference in
nitrogen retention by calves fed soy based milk replacers.
SUMMARY
Thermoplastic extrusion was studied as a means of processing soy flour for
use in milk replacer for calves. This method of processing generally reduced
trypsin inhibitor to a low level. Extrusion of soy flour with sulfur, low pH,
high salt, high moisture and at high temperature gave a product low in
antimetabolites. Milk replacers based on this extruded soy failed to support
calf performance equal to that on milk protein based milk replacer,
particularly in calves <2 wks of age. Mild acidification of the soy milk
replacer appeared beneficial to calves <2 weeks of age. Methionine and
lysine supplementation of soy milk replacer was not of benefit and may
have been detrimental to calf performance. The nitrogen retained by soy
fed calves (in experiments 1 and 2) was lower than with milk fed calves,
particularly for calves <3 weeks of age. This suggests that digestibility may
be a problem with intensive use of soy proteins in milk replacers.
Thermoplastic extrusion can modify soy flour to the extent of inactivating
the recognized antimetabolites. Further work may develop a more digestible
product, suitable for use with young calves. Also worth investigating is the
potential benefit to the young calf from acidification of milk replacer.
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APPENDIX
TABLE X, Thermoplastic extrusion of soy flour - Processing parameters.
Extrusion Flow at the die
*
Volume change
Product kg dry matter min~ m kg
1 1.195 1.08
2 1.176 1.29
3 1.470 1.60
4 1.362 1.74
5 1.421
.98
6 1.263 1.05
7 1.481 2.06
8 1.420 1.67
9 1.424 3.03
10 1.388 5.13
11 1.499 2.37
12 1.385 2.98
13 1.343 2.84
14 1.390 3.80
15 1.323 1.76
16 1.198 2.38
17 1.336 1.13
18 1.137 1.22
19 1.199 1.00
20 1.185
.74
21 1.316 1.50
22 1.295 1.40
23 1.400 1.27
24 1.409 1.03
25 1.351 2.20
26 1.336 3.81
27 1.335 1.51
28 1.330 1.79
29 1.352 1.79
30 1.238 2.26
31 1.398 2.12
32 1.335 1.66
Calculated as the volume (m 3 ) of the product per kg dry matter
minus the volume (m 3 ) of raw material per kg dry matter.
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Experiment 1. MetabcOic, physiological and immunological parameters
were monitored in preruminant calves fed one of four milk replacers.
Protein sources for the milk replacers were all milk (AM) or 25% miDc
protein and 75% protein from either soy protein concentrate (SPC),
commercial soy flour (CSF) or experimental soy flour (ESF). The
experimental soy flour had trypsin inhibitor activity of <1 unit/mg. Using
the nitrogen retained at 3 and 6 wks, the presence of abnormal intestinal
mucosa, growth rates and the development of circulatory immunoglobulins
specific to soy proteins, the three soy-based milk replacers were inferior to
the AM milk replacer. The soy-based diets induced a marked
antibody-mediated allergic response in the calves, with no major difference
in this response between soy products. There was no cell-mediated immune
response to any of the soy products. Calves showed improved performance
with age, particularly on the soy-based diets. Milk replacers SPC and ESF
gave comparable calf performance, both being superior to CSF.
Experiment 2. Enzyme active soy flour was used as the starting
material for thermoplastic extrusion processing. Five processing conditions
were varied in a 5 X 2 factorial design resulting in 32 products. All
extrusion products had >90% reduction in trypsin inhibitor (TD activity. The
extrusion products had a wide range of antigenic (glycinin and
fl-conglycinin) activities, these were not closely related. Only one product
had no detectable activity for both glycinin and 3-conglycinin. This "antigen
free" extrusion product had very low TI activity (1 unit/mg) and was used
as the maj3r protein source (70%) in three experimental milk replacers. The
effects of amino acid supplementation and acidification of milk replacers
based on the extruded soy were also studied. Metabolic and growth response
of calves were used to compare the experimental milk replacers with an all
milk protein controL The extruded soy was inferior to miHc as a protein
source for milk replacers. AA supplementation of soy was detrimental to
calf performance. Acidification of soy based milk replacer had some benefit
in the young «3 wks old) calf, but was not beneficial later.
